Back to results
US 2019/0167708 A1Published application
Tumor suppressor tet1 and uses thereof
AssigneeThe Chinese University of Hong Kong
InventorsQian TAO, Lili LI
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for assessing the risk of cancer in a subject by detecting elevated methylation level in the genomic sequence of the TET1 gene, which leads to suppressed expression of this gene. A kit and device useful for practicing such a method are also provided.
Claims9
1-20. (canceled)
A compound of Formula II-IX having the any one of the following structures:
A mixture comprising differentiated cells and a compound of Formula II-IX having any one of the following structures:
Dependencies are inferred from the claim text.